Challenging Dogma about Myonuclei Behavior in Skeletal Muscle Cells.

As I think about my time in graduate school or as a postdoc, I remember reading countless papers with some version of the following phrase “skeletal muscle is postmitotic. . .” or “DNA synthesis does not occur after fusion. . .” Collectively these statements are something I always accepted as proven and something I would venture to say that most individuals, who study skeletal muscle would consider dogma. Thus, reading the work of Borowik et al.1 in this issue of Function, caused me to stop and really focus on the data because the ideas challenged these very same concepts. Perhaps, this illustrates the dangers of the word “dogma” in science. As previously suggested by others, it may be better to think that the concept of postmitotic myonuclei was never dogma but instead a paradigm of understanding based on a wealth of published evidence.2 The paradigm of postmitotic myonuclei was established across multiple labs using a variety of scientific approaches, which provided confidence to the field that paradigm was valid due to the high degree of rigor3–6. The work in this issue of Function by Borowik et al.,1 demonstrates increases in DNA synthesis in myonuclei, which would suggest myonuclear replication is occurring. Within the manuscript, the authors provide a synopsis describing a sequence of publications that led them to test if DNA synthesis may be occurring in myonuclei. Specifically, the authors had published papers describing increases in DNA synthesis in skeletal muscle across a variety of models (ie, exercise in humans or mechanical stimulation of muscle in mice). Although not proven, the authors assumed that satellite cell expansion explained the DNA synthesis measures. Thus, in this current study, the authors used a genetic mouse model where satellite cells were ablated, and they hypothesized that no increases in DNA synthesis should be detected. Surprisingly, the data indicated an increase in DNA synthesis even when the satellite cells were ablated, which the authors interpreted to mean that the increase was due to proliferation of nonmuscle cells. Before proceeding to nonmuscle cells, the authors sought to rule out myonuclei as the source of DNA synthesis. To accomplish this, the authors developed a mouse model where a skeletal muscle-specific Tet-On mouse (HSA-rtTA) was crossed with a tetracycline-response element histone 2B-green fluorescent protein mouse (TRE-H2B-GFP). Using this mouse, allowed the investigators the ability to sort the GFP+ myonuclei and sort the GFP− nuclei (from nonmuscle cells) into two distinct fractions. The authors confirmed the ability to separate two fractions using multiple different approaches. Upon confirmation that isolation of myonuclei was possible, they then delivered deuterium oxide (D2O) to the animals, which will only incorporate into DNA using de novo pathways ruling out any signal accumulation due to DNA repair. After the D2O exposure, the investigators were able to isolate the different fractions and directly measure D2O labeling. Under normal cage conditions, the authors found that 10% of the total DNA synthesis occurred in the GFP+ fraction (ie, myonuclei); however, if the authors induced muscle hypertrophy, a significant increase in DNA synthesis was detected in the GFP+ fraction suggesting that the myonuclei are replicating. Using mathematical predictions, their data suggest that in resting conditions 2.5%–8% of the resident nuclei replicate their DNA in a year, which on face value seems low; however, when the muscle was loaded the increase equated to hundreds to thousands of replication events over a 2.5-mo period. These results are quantitively similar to work on myonuclei response to denervation.7 Thus, the data suggest that myonuclei are not postmitotic. In the paper, the authors employed multiple different approaches coupled with a variety of validation techniques,